Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcoma 12Lymphoma, Large B-Cell, Diffuse 12Sarcoma, Ewing 4Lymphoma, B-Cell 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Neurofibrosarcoma 3Lymphoma, Non-Hodgkin 3Liposarcoma 3Hodgkin Disease 3Fibrosarcoma 3Sarcoma, Synovial 2Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Nerve Sheath Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Follicular 2Lymphoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Histiocytoma, Angiomatoid Fibrous 2Hemangiosarcoma 2Granuloma, Plasma Cell 2Desmoplastic Small Round Cell Tumor 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Burkitt Lymphoma 2

Interventions

Cyclophosphamide 13Prednisone 10N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 9Doxorubicin 9Vincristine 8Azacitidine 6romidepsin 5Gemcitabine 5Brentuximab Vedotin 5fludarabine 4Etoposide 4Dexamethasone 4pembrolizumab 3belinostat 3Lenalidomide 3Biopsy 310-propargyl-10-deazaaminopterin 3tazemetostat 2ruxolitinib 2ixazomib 2duvelisib 2Nivolumab 2Bendamustine Hydrochloride 2venetoclax 1tislelizumab 1thymoglobulin 1spartalizumab 1somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- 1sodium-iodide symporter 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Ifosfamide × 1 year × Clear all
NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡